Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Sales (2022 - 2025)

Historic Return on Sales for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 219.09%.

  • HCW Biologics' Return on Sales fell 2099200.0% to 219.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.19%, marking a year-over-year decrease of 194700.0%. This contributed to the annual value of 11.73% for FY2024, which is 25800.0% down from last year.
  • Latest data reveals that HCW Biologics reported Return on Sales of 219.09% as of Q3 2025, which was down 2099200.0% from 563.78% recorded in Q2 2025.
  • HCW Biologics' Return on Sales' 5-year high stood at 0.6% during Q1 2022, with a 5-year trough of 563.78% in Q2 2025.
  • Its 4-year average for Return on Sales is 95.82%, with a median of 8.13% in 2023.
  • Per our database at Business Quant, HCW Biologics' Return on Sales skyrocketed by 1235700bps in 2024 and then crashed by -5390700bps in 2025.
  • HCW Biologics' Return on Sales (Quarter) stood at 4.29% in 2022, then crashed by -89bps to 8.13% in 2023, then fell by -6bps to 8.63% in 2024, then crashed by -2438bps to 219.09% in 2025.
  • Its Return on Sales was 219.09% in Q3 2025, compared to 563.78% in Q2 2025 and 438.62% in Q1 2025.